Cart
sales@molnova.com
Laudanosine
CAS No. 1699-51-0
Laudanosine( DL-LAUDANOSINE )
Catalog No. M21227 CAS No. 1699-51-0
Laudanosine is a recognized metabolite of atracurium and cisatracurium.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 84 | In Stock |
|
| 50MG | 122 | In Stock |
|
| 100MG | 177 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLaudanosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLaudanosine is a recognized metabolite of atracurium and cisatracurium.
-
DescriptionLaudanosine is a recognized metabolite of atracurium and cisatracurium.
-
In Vitro——
-
In VivoDL-Laudanosine (Laudanosine) appears to be unique in its ability to produce cerebral stimulation in lightly anaesthetized animals and it is reported to cause arousal from anaesthesia in subconvulsive doses. Animal Model:Male CFLP mice weighing 18-25 g, and male Wistar rats weighing 120-150 g .Dosage:10-20 mg/kg.Administration:IV.Result:Caused convulsions and hind limb extensions.
-
SynonymsDL-LAUDANOSINE
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1699-51-0
-
Formula Weight357.4
-
Molecular FormulaC21H27NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (279.77 mM)
-
SMILESCN(CCc1c2)C(Cc(cc3)cc(OC)c3OC)c1cc(OC)c2OC
-
Chemical Name1-(34-dimethoxybenzyl)-67-dimethoxy-2-methyl-1234-tetrahydroisoquinoline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shi W Z Fahey M R Fisher D M et al. Laudanosine (A Metabolite of Atracurium) Increases the Minimum Alveolar Concentration of Halothane in Rabbits[J]. Anesthesiology 1985 63(6):584-588.
molnova catalog
related products
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.
-
Vilobelimab
Vilobelimab (CaCP-29, IFX-1), a monoclonal antibody targeting C5a, inhibits this pro-inflammatory complement component, which is pivotal in causing organ dysfunction.
-
TP0586532
TP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.
